EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 25 / No 3 (Mars 2009) Med Sci (Paris), 25 3 (2009) 247-252 References
Free Access
Issue
Med Sci (Paris)
Volume 25, Number 3, Mars 2009
Page(s) 247 - 252
Section M/S revues
DOI https://doi.org/10.1051/medsci/2009253247
Published online 15 March 2009
  1. Beauchemin N, Draber P, Dveksler G, et al. Redefined nomenclature for members of the carcinoembryonic antigen family. Exp Cell Res 1999; 252 : 243–9. [Google Scholar]
  2. Gray-Owen SD, Blumberg RS. CEACAM1: contact-dependent control of immunity. Nat Rev Immunol 2006; 6 : 433–46. [Google Scholar]
  3. Létourneau S, Beauchemin N. Rôles des antigènes carcino-embryonnaires dans la cancérisation et la progression tumorale. Med Sci (Paris) 1997; 13 : 483–91. [Google Scholar]
  4. Hemmila E, Turbide C, Olson M, et al. Ceacam1a−/− mice are completely resistant to infection by murine coronavirus mouse hepatitis virus A59. J Virol 2004; 78 : 10156–65. [Google Scholar]
  5. Najjar SM. Regulation of insulin action by CEACAM1. Trends Endocrinol Metab 2002; 13 : 240–5. [Google Scholar]
  6. Poy MN, Yang Y, Rezaei K, et al. CEACAM1 regulates insulin clearance in liver. Nat Genet 2002; 30 : 270–6. [Google Scholar]
  7. Xu E. Targeted disruption of Ceacam1 promotes diet-induced hepatic steatosis and insulin resistance. Endocrinology 2009 (sous presse). [Google Scholar]
  8. Formisano P, Najjar SM, Gross CN, et al. Receptor-mediated internalization of insulin. Potential role of pp120/HA4, a substrate of the insulin receptor kinase. J Biol Chem 1995; 270 : 24073–7. [Google Scholar]
  9. Horst A, Wagener C. CEA-related CAMs. Hum Exp Pharmacol 2004; 165 : 283–341. [Google Scholar]
  10. Simeone DM, Ji B, Banerjee M, et al. CEACAM1, a novel serum biomarker for pancreatic cancer. Pancreas 2007; 34 : 436–43. [Google Scholar]
  11. Kunath T, Ordoñez-Garcia C, Turbide C, Beauchemin N. Inhibition of colonic tumor cell growth by biliary glycoprotein. Oncogene 1995; 11 : 2375–82. [Google Scholar]
  12. Phan D, Cheng CJ, Galfione M, et al. Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesis. Cancer Res 2004; 64 : 3072–8. [Google Scholar]
  13. Beauchemin N, Kunath T, Robitaille J, et al. Association of biliary glycoprotein with protein tyrosine phosphatase SHP-1 in malignant colon epithelial cells. Oncogene 1997; 14 : 783–90. [Google Scholar]
  14. Izzi L, Turbide C, Houde C, Kunath T, Beauchemin N. Cis-determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function. Oncogene 1999; 18 : 5563–72. [Google Scholar]
  15. Leung N, Turbide C, Balachandra B, et al. Intestinal tumor progression is promoted by decreased apoptosis and dysregulated Wnt signaling in Ceacam1−/− mice. Oncogene 2009; 27 : 4943–53. [Google Scholar]
  16. Leung N, Turbide C, Olson M, et al. Deletion of the carcinoembryonic antigen-related cell adhesion molecule 1 (Ceacam1) gene contributes to colon tumor progression in a murine model of carcinogenesis. Oncogene 2006; 25 : 5527–36. [Google Scholar]
  17. Liu W, Wei W, Winer D, et al. CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastase s. Oncogene 2007; 26 : 2747–58. [Google Scholar]
  18. Obrink B. On the role of CEACAM1 in cancer. Lung Cancer 2008; 60 : 309–12. [Google Scholar]
  19. Ebrahimnejad A, Streichert T, Nollau P, et al. CEACAM1 enhances invasion and migration of melanocytic and melanoma cells. Am J Pathol 2004; 165 : 1781–7. [Google Scholar]
  20. Ergün S, Kilik N, Ziegeler G, et al. CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor. Mol Cell 2000; 5 : 311–20. [Google Scholar]
  21. Horst AK, Ito WD, Dabelstein J, et al. Carcinoembryonic antigen-related cell adhesion molecule 1 modulates vascular remodeling in vitro and in vivo. J Clin Invest 2006; 116 : 1596–605. [Google Scholar]
  22. Kilic N, Oliveira-Ferrer L, Wurmbach JH, et al. Pro-angiogenic signaling by the endothelial presence of CEACAM1. J Biol Chem 2005; 28 : 2361–9. [Google Scholar]
  23. Müller MM, Singer BB, Klaile E, et al. Transmembrane CEACAM1 affects integrin-dependent signaling and regulates extracellular matrix protein-specific morphology and migration of endothelial cells. Blood 2005; 105 : 3925–34. [Google Scholar]
  24. Tilki D, Irmak S, Oliveira-Ferrer L, et al. CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer. Oncogene 2006; 25 : 4965–74. [Google Scholar]
  25. Oliveira-Ferrer L, Tilki D, Ziegeler G, et al. Dual role of carcinoembryonic antigen-related cell adhesion molecule 1 in angiogenesis and invasion of human urinary bladder cancer. Cancer Res 2004; 64 : 8932–8. [Google Scholar]
  26. Kilic N, Oliveira-Ferrer L, Neshat-Vahid S, et al. Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1. Blood 2007; 110 : 4223–33. [Google Scholar]
  27. Nagaishi T, Pao L, Lin SH, et al. SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. Immunity 2006; 25 : 769–81. [Google Scholar]
  28. Donda A, Mori L, Shamshiev A, et al. Locally inducible CD66a (CEACAM1) as an amplifier of the human intestinal T cell response. Eur J Immunol 2000; 30 : 2593–603. [Google Scholar]
  29. Chen Z, Chen L, Qiao SW, et al. Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits proximal TCR signalling by targeting ZAP-70. J Immunol 2008; 180 : 6085–93. [Google Scholar]
  30. Markel G, Lieberman N, Katz G, et al. CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity. J Immunol 2002; 168 : 2803–10. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.